InfoSynergy
Probiotics
Combining BB536 with other probiotic strains may broaden microbiome effects but can increase gas or make attribution difficult.
Recommendation: Add one strain at a time and use products listing full strain IDs.
Bifidobacterium longum BB536
Probiotic ·Moderate evidence ·Reviewed May 2026
Bifidobacterium longum BB536 is a well-characterized probiotic strain used in foods and supplements and studied for constipation, bowel movement frequency, and immune modulation. Evidence is strongest for strain-specific products rather than generic Bifidobacterium labels. It is usually well tolerated in healthy adults but requires caution in severe immunocompromise or critical illness.
What it's good for
What to watch for
- Temporary gas, bloating, or stool changes
- Mild abdominal discomfort during initiation
- Rare bacteremia or infection in severely immunocompromised patients
- Severe immunocompromise, neutropenia, central venous catheter, or critical illness without clinician guidance
- Short bowel syndrome or D-lactic acidosis history without specialist input1,2
The bottom line
Evidence rating moderate. Most-documented uses: may improve bowel movement frequency in constipation, supports bifidobacteria abundance, may support immune balance and gut barrier function. 3 sources indexed (2013–2023), with 3 interaction records on file.
The science
How it works, mechanistically.
Core mechanism
BB536 can transiently increase fecal bifidobacteria, modify fermentation patterns, and influence bile acid and short-chain fatty acid-related metabolites. These changes may improve stool frequency, stool consistency, and gut barrier signaling. Like other probiotics, it does not permanently colonize most adults and benefits generally require ongoing intake.3,2
Class
Bifidobacterium probiotic for bowel regularity and immune support
Found in food
Commercial fermented milk or probiotic products listing BB536, Generic fermented foods do not reliably contain BB536
Low-status signs
No Bifidobacterium longum BB536-specific deficiency; dysbiosis may be associated with symptoms but absence of this strain is not a standalone deficiency diagnosis.
Absorption
Water-soluble; take with food
Dosing
Dosing & protocol.
Common range
1-20 billion CFU daily; many studies use around 10 billion CFU/day
Recommended form
Strain-verified BB536 capsule, sachet, or fermented product with CFU guaranteed through expiration
Probiotics act locally in the gut rather than being absorbed like nutrients. Taking with food may improve survival through gastric acid; avoid hot liquids.2
Forms
Forms & what to buy.
Ranked by evidence and value.
BB536 Capsule Recommended
Strain-verified capsule with CFU through expiration best matches evidence. Take with food; avoid hot liquids.
BB536 Sachet Powder
Can deliver higher CFU and is easy to mix into cool foods. Mix with cool or room-temperature food.
BB536 Fermented Dairy Product
Food matrix may support adherence but contains dairy. Consume consistently and verify strain on label.
Cost
What it actually costs.
Real-world pricing across three quality tiers. Assumes BB536 capsule.
BudgetBest value
$11 /mo
$0.35 per dose
Mid
$24 /mo
$0.80 per dose
Premium
$48 /mo
$1.60 per dose
Strain-verified BB536 products are more expensive than generic probiotic blends but better match clinical evidence. Updated 2026-06-04.
Goals
Goal-based dosing.
Constipation Support
Dose: 5-20 billion CFU daily for 4-12 weeks1
Timing: With breakfast
Assess bowel frequency, stool form, and bloating over several weeks.
Microbiome Support
Dose: 1-10 billion CFU daily2
Timing: With meals
Benefits are strain-specific and often fade after stopping.
Immune Balance
Dose: 1-10 billion CFU daily
Timing: With food
Evidence is supportive but not a substitute for vaccines, sleep, and infection prevention.
Why people use it
Symptoms it's matched to.
Where this appears in the symptom-to-supplement map, ranked by relevance.
Constipation
68% relevance
BB536 trials suggest improved bowel frequency and constipation symptoms.1,2
DigestiveModerate evidenceBB536 capsule or sachet
Use with fluids and dietary fiber as tolerated.
Irregular bowel habits
52% relevance
Microbiome and metabolome changes may support more regular bowel patterns.2,1
DigestiveEmerging evidenceStrain-verified BB536
Track stool form and frequency over 4-8 weeks.
Low immune resilience
32% relevance
Bifidobacteria may modulate mucosal immune signaling, though clinical immune outcomes vary.
ImmuneEmerging evidenceBB536 capsule
Not a substitute for vaccination or medical care.
Safety
Full safety detail.
Side effects
- Temporary gas, bloating, or stool changes
- Mild abdominal discomfort during initiation
- Rare bacteremia or infection in severely immunocompromised patients
- Allergic reaction to product excipients
Contraindications
Interactions
Interaction records.
ModerateTiming Sensitive
Berberine
Berberine has antimicrobial properties that may reduce probiotic viability if taken together.
Recommendation: Separate berberine and BB536 by at least 2-3 hours.
InfoSynergy
Zinc
Zinc and probiotics may both support mucosal immune function, though direct BB536-zinc trial data are limited.
Recommendation: Reasonable to combine at standard zinc doses; avoid chronic high-dose zinc unless monitored.
Search all 3 interaction records for Bifidobacterium longum BB536 →
Sources
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Randomized controlled trials
2- 1Usefulness of Bifidobacterium longum BB536 in Elderly Individuals With Chronic Constipation: A Randomized Controlled TrialNeeds reviewNo linkTakii H et al. · American Journal of Gastroenterology · 2023
BB536 improved constipation scoring and bowel-related outcomes compared with placebo.
- 2Integrated gut microbiome and metabolome analyses identified fecal biomarkers for bowel movement regulation by Bifidobacterium longum BB536 supplementation: A RCTNeeds reviewNo linkFukuda S et al. · Gut Microbes · 2022
Microbiome and metabolome profiling identified response-related markers during BB536 supplementation.
Reference material
1- 3Modulatory effects of Bifidobacterium longum BB536 on defecation in elderly patients receiving enteral feedingNeeds reviewNo linkMatsumoto M et al. · World Journal of Gastroenterology · 2013
BB536 altered defecation patterns and fecal microbiota in elderly patients receiving enteral nutrition.
Keep exploring
Deep dives & adjacent profiles.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Bifidobacterium longum BB536 in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.